DR. RENE VEYTIA

Dr. Rene Veytia brings over 15 years of medical leadership and 8+ years of specialized experience in pharmaceutical and biotech clinical development to every study he oversees. His background spans clinical trial operations in a multitude of theraputic areas, surgical and perioperative medicine, and cross-border healthcare leadership across the U.S. and Latin America.

As Director of Clinical Trials, Dr. Veytia leads every stage of study execution — from site feasibility and protocol implementation to CRO oversight, budget and timeline management, and full regulatory compliance with FDA, EMA, and ICH-GCP standards. He is Good Clinical Practice (ICH E6) and IATA certified for clinical trial materials handling, with additional credentials in Advanced Cardiac Life Support, Neonatal Resuscitation, and emergency medicine. His hands-on leadership of a high-volume surgical center — performing 500+ procedures annually at a less than 0.5% complication rate — reflects the same rigor and safety discipline he brings to clinical research.

Bilingual and bicultural, Dr. Veytia has spent his career bridging clinical excellence with operational precision across the U.S.–Mexico region. For sponsors, physicians, and trial participants alike, that means studies run with uncompromising attention to safety, compliance, and the people at the center of every trial.

Key Achievements

Clinical Development: 8+ years pharmaceutical experience developing Clinical Development Plans and leading programs in GI/rare disease
Medical Affairs: MSL and Medical Affairs Manager experience across Mexico and LATAM
Pharmacovigilance: Expertise in RMPs/REMS, PSURs/PBRERs, Core Safety Information, ICH/GVP compliance
Governance: Established global Medical Affairs SOPs and led inspection readiness
Clinical Operations: Managed trial timelines, budgets, CROs, and TMF documentation
Patient Safety: <0.5% complication rate across 500+ annual procedures
Regulatory: FDA, EMA, ICH, GCP, and PhRMA Code expertise
Leadership: Mentored clinical teams and directed cross-functional operations